Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Alginates × 1 year × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Mucositis 1 Esophagitis 1 Breast Neoplasms 1

Interventions

pembrolizumab 462 Carboplatin 330 Specimen Handling 325 Cisplatin 288 Magnetic Resonance Spectroscopy 287 Nivolumab 274 Cyclophosphamide 260 Paclitaxel 231 Radiotherapy 217 Biopsy 200 Gemcitabine 192 Bevacizumab 183 Dexamethasone 152 durvalumab 146 Rituximab 144 Capecitabine 139 atezolizumab 138 Oxaliplatin 138 Docetaxel 135 Fluorouracil 134 venetoclax 131 Ipilimumab 121 Etoposide 120 Drug Therapy 120 Doxorubicin 113 Prednisone 111 Lenalidomide 109 Radiosurgery 104 Pemetrexed 98 Leucovorin 98

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡